封面
市場調查報告書
商品編碼
1788504

生物技術市場-全球產業分析、規模、佔有率、成長、趨勢及預測(2025-2035)

Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日期: | 出版商: Transparency Market Research | 英文 208 Pages | 商品交期: 2-10個工作天內

價格

生物技術市場-報告範圍

TMR 的全球生物技術市場報告研究了過去和當前的成長趨勢和機遇,以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2025 年至 2035 年期間全球生技市場的收入,以 2025 年為基準年,2035 年為預測年。該報告也提供了 2025 年至 2035 年全球生物技術市場的年複合成長率(CAGR %)。

本報告經過廣泛調查後編寫。主要研究工作包括分析師對關鍵意見領袖、產業領導者和輿論領袖進行訪談。次要研究則參考了主要廠商的產品資料、年度報告、新聞稿和相關文件,以了解二輪車導航顯示器市場。

市場概況
2024 年的市場價值 1.8兆美元
2035年的市場價值 5.4兆美元
複合年成長率 10.3%

本報告深入探討了全球二輪車導航顯示器市場的競爭格局。報告確定了全球生物技術市場的主要參與者,並根據其各項屬性進行了分析。本報告對全球生物技術市場參與者的屬性進行了分析,涵蓋公司概況、財務狀況、近期發展和 SWOT 分析。

全球生物技術市場報告解答的關鍵問題:

  • 預測期內,所有地區的血液分離術所產生的銷售額/收入為何?
  • 全球二輪車導航顯示器市場有哪些機會?
  • 市場的主要促進因素、限制因素、機會和威脅是什麼?
  • 在預測期內,哪個區域市場將以最快的複合年成長率擴張?
  • 預計哪個領域將在 2035 年創造全球最高收入?
  • 預測期間哪一個部分的複合年成長率預計最高?
  • 在全球市場上營運的不同公司的市場地位如何?

生物技術市場-研究目標與研究方法

這份關於全球生物技術市場的綜合報告首先概述了研究範圍和目標。報告詳細闡述了本研究的目標、市場中的主要供應商和分銷商,以及產品核准的監管情況。

為了方便閱讀,本報告採用章節式佈局,每個章節又細分為多個小節。報告包含詳盡的圖表,並適當穿插。各關鍵細分市場的實際值和預測值以圖形方式呈現,視覺上引人入勝。此外,報告也便於讀者比較過去和預測期末各關鍵細分市場的市佔率。

本報告從產品、最終用戶和地區三個角度分析了全球生物技術市場。該報告對每個標準下的關鍵細分市場進行了深入研究,並提供了截至2035年底每個細分市場的市場佔有率。這些寶貴的洞察有助於市場利害關係人在全球二輪車導航顯示器市場投資時做出明智的商業決策。

目錄

第1章:前言

第2章:假設與研究方法

第3章:執行摘要:全球市場

第4章:市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020年至2035年全球生技市場分析與預測

第5章:關鍵見解

  • 主要地區/國家的醫療保健支出
  • 技術進步
  • 主要地區/國家的監管情況
  • 波特五力分析
  • PESTEL分析
  • 價值鏈分析
  • 最終用戶的關鍵購買指標
  • 新市場進入者的市場進入策略
  • 重要產業事件(合作夥伴關係、協作、產品批准、合併和收購)
  • 與領先競爭對手的關鍵技術基準化分析

第6章:全球市場分析與預測:依技術

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2035 年各技術市場價值預測
    • 聚合酶鍊式反應(PCR)技術
    • 組織工程與再生
    • 奈米生物技術
    • 色譜法
    • DNA定序
    • 基於細胞的檢測
    • 發酵
    • 生物資訊學
    • 其他
  • 按技術分類的市場吸引力

第7章:全球市場分析與預測:按應用

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2035 年各應用市場價值預測
    • 衛生保健
    • 農業
    • 食品和飲料
    • 工業生物技術
    • 環境生物技術
    • 其他
  • 按應用分類的市場吸引力

第8章:全球市場分析與預測:按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第9章:北美市場分析與預測

  • 美國
  • 加拿大

第10章:歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 瑞士
  • 荷蘭
  • 歐洲其他地區

第 11 章:亞太市場分析與預測

  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲和紐西蘭
  • 亞太其他地區

第12章:拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區

第13章:中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 14 章:競爭格局

  • 市場參與者 - 競爭矩陣(依公司層級和規模)
  • 各公司市佔率分析(2024 年)
  • 公司簡介
    • Abbott
    • AstraZeneca
    • Pfizer Inc.
    • F. Hoffmann-La Roche AG
    • Novartis AG
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • Novo Nordisk A/S
    • Merck KGaA
    • Johnson & Johnson Services, Inc.
    • Amgen Inc.
    • GSK plc
    • Sanofi
    • Thermo Fisher Scientific Inc.
    • AbbVie Inc.
    • Bristol-Myers Squibb Company
    • Teva Pharmaceutical Industries Ltd.
    • Gilead Sciences, Inc.
    • Biogen Inc.
    • Moderna, Inc.
Product Code: TMRGL86738

Biotechnology Market- Scope of Report

TMR's report on the global Biotechnology Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global Biotechnology Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Biotechnology Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display market.

Market Snapshot
Market Value in 2024US$ 1.8 Tn
Market Value in 2035US$ 5.4 Tn
CAGR10.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global two-wheeler navigation display market.

The report delves into the competitive landscape of the global two-wheeler navigation display market. Key players operating in the global Biotechnology Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Biotechnology Marketprofiled in this report.

Key Questions Answered in Global Biotechnology MarketReport:

  • What is the sales/revenue generated by apheresis across all regions during the forecast period?
  • What are the opportunities in the global two-wheeler navigation display market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Biotechnology Market- Research Objectives and Research Approach

The comprehensive report on the global Biotechnology Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Biotechnology Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Biotechnology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Biotechnology Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Tn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Technological Advancements
  • 5.3. Regulatory Scenario across Key Regions / Countries
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. PESTEL Analysis
  • 5.6. Value Chain Analysis
  • 5.7. Key Purchase Metrics for End-users
  • 5.8. Go-to-Market Strategy for New Market Entrants
  • 5.9. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers & acquisitions)
  • 5.10. Benchmarking of Key Technologies Offered by the Leading Competitors

6. Global Biotechnology Market Analysis and Forecasts, By Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Technology, 2020 to 2035
    • 6.3.1. Polymerase Chain Reaction (PCR) Technology
    • 6.3.2. Tissue Engineering and Regeneration
    • 6.3.3. Nanobiotechnology
    • 6.3.4. Chromatography
    • 6.3.5. DNA Sequencing
    • 6.3.6. Cell-based Assays
    • 6.3.7. Fermentation
    • 6.3.8. Bioinformatics
    • 6.3.9. Others
  • 6.4. Market Attractiveness By Technology

7. Global Biotechnology Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020 to 2035
    • 7.3.1. Healthcare
    • 7.3.2. Agriculture
    • 7.3.3. Food & Beverages
    • 7.3.4. Industrial Biotechnology
    • 7.3.5. Environmental Biotechnology
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Application

8. Global Biotechnology Market Analysis and Forecasts, By Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness By Region

9. North America Biotechnology Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast By Technology, 2020 to 2035
    • 9.2.1. Polymerase Chain Reaction (PCR) Technology
    • 9.2.2. Tissue Engineering and Regeneration
    • 9.2.3. Nanobiotechnology
    • 9.2.4. Chromatography
    • 9.2.5. DNA Sequencing
    • 9.2.6. Cell-based Assays
    • 9.2.7. Fermentation
    • 9.2.8. Bioinformatics
    • 9.2.9. Others
  • 9.3. Market Value Forecast By Application, 2020 to 2035
    • 9.3.1. Healthcare
    • 9.3.2. Agriculture
    • 9.3.3. Food & Beverages
    • 9.3.4. Industrial Biotechnology
    • 9.3.5. Environmental Biotechnology
    • 9.3.6. Others
  • 9.4. Market Value Forecast By Country, 2020 to 2035
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Technology
    • 9.5.2. By Application
    • 9.5.3. By Country

10. Europe Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Technology, 2020 to 2035
    • 10.2.1. Polymerase Chain Reaction (PCR) Technology
    • 10.2.2. Tissue Engineering and Regeneration
    • 10.2.3. Nanobiotechnology
    • 10.2.4. Chromatography
    • 10.2.5. DNA Sequencing
    • 10.2.6. Cell-based Assays
    • 10.2.7. Fermentation
    • 10.2.8. Bioinformatics
    • 10.2.9. Others
  • 10.3. Market Value Forecast By Application, 2020 to 2035
    • 10.3.1. Healthcare
    • 10.3.2. Agriculture
    • 10.3.3. Food & Beverages
    • 10.3.4. Industrial Biotechnology
    • 10.3.5. Environmental Biotechnology
    • 10.3.6. Others
  • 10.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 10.4.1. Germany
    • 10.4.2. UK
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Switzerland
    • 10.4.7. The Netherlands
    • 10.4.8. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Technology
    • 10.5.2. By Application
    • 10.5.3. By Country / Sub-region

11. Asia Pacific Biotechnology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Technology, 2020 to 2035
    • 11.2.1. Polymerase Chain Reaction (PCR) Technology
    • 11.2.2. Tissue Engineering and Regeneration
    • 11.2.3. Nanobiotechnology
    • 11.2.4. Chromatography
    • 11.2.5. DNA Sequencing
    • 11.2.6. Cell-based Assays
    • 11.2.7. Fermentation
    • 11.2.8. Bioinformatics
    • 11.2.9. Others
  • 11.3. Market Value Forecast By Application, 2020 to 2035
    • 11.3.1. Healthcare
    • 11.3.2. Agriculture
    • 11.3.3. Food & Beverages
    • 11.3.4. Industrial Biotechnology
    • 11.3.5. Environmental Biotechnology
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 11.4.1. China
    • 11.4.2. India
    • 11.4.3. Japan
    • 11.4.4. South Korea
    • 11.4.5. Australia & New Zealand
    • 11.4.6. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Technology
    • 11.5.2. By Application
    • 11.5.3. By Country / Sub-region

12. Latin America Biotechnology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Technology, 2020 to 2035
    • 12.2.1. Polymerase Chain Reaction (PCR) Technology
    • 12.2.2. Tissue Engineering and Regeneration
    • 12.2.3. Nanobiotechnology
    • 12.2.4. Chromatography
    • 12.2.5. DNA Sequencing
    • 12.2.6. Cell-based Assays
    • 12.2.7. Fermentation
    • 12.2.8. Bioinformatics
    • 12.2.9. Others
  • 12.3. Market Value Forecast By Application, 2020 to 2035
    • 12.3.1. Healthcare
    • 12.3.2. Agriculture
    • 12.3.3. Food & Beverages
    • 12.3.4. Industrial Biotechnology
    • 12.3.5. Environmental Biotechnology
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Argentina
    • 12.4.4. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Technology
    • 12.5.2. By Application
    • 12.5.3. By Country / Sub-region

13. Middle East & Africa Biotechnology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Technology, 2020 to 2035
    • 13.2.1. Polymerase Chain Reaction (PCR) Technology
    • 13.2.2. Tissue Engineering and Regeneration
    • 13.2.3. Nanobiotechnology
    • 13.2.4. Chromatography
    • 13.2.5. DNA Sequencing
    • 13.2.6. Cell-based Assays
    • 13.2.7. Fermentation
    • 13.2.8. Bioinformatics
    • 13.2.9. Others
  • 13.3. Market Value Forecast By Application, 2020 to 2035
    • 13.3.1. Healthcare
    • 13.3.2. Agriculture
    • 13.3.3. Food & Beverages
    • 13.3.4. Industrial Biotechnology
    • 13.3.5. Environmental Biotechnology
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Technology
    • 13.5.2. By Application
    • 13.5.3. By Country / Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis By Company (2024)
  • 14.3. Company Profiles
    • 14.3.1. Abbott
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. Business Strategies
      • 14.3.1.5. Recent Developments
    • 14.3.2. AstraZeneca
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. Business Strategies
      • 14.3.2.5. Recent Developments
    • 14.3.3. Pfizer Inc.
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. Business Strategies
      • 14.3.3.5. Recent Developments
    • 14.3.4. F. Hoffmann-La Roche AG
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. Business Strategies
      • 14.3.4.5. Recent Developments
    • 14.3.5. Novartis AG
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. Business Strategies
      • 14.3.5.5. Recent Developments
    • 14.3.6. Merck & Co., Inc.
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. Business Strategies
      • 14.3.6.5. Recent Developments
    • 14.3.7. Eli Lilly and Company
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. Business Strategies
      • 14.3.7.5. Recent Developments
    • 14.3.8. Novo Nordisk A/S
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. Business Strategies
      • 14.3.8.5. Recent Developments
    • 14.3.9. Merck KGaA
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. Business Strategies
      • 14.3.9.5. Recent Developments
    • 14.3.10. Johnson & Johnson Services, Inc.
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. Business Strategies
      • 14.3.10.5. Recent Developments
    • 14.3.11. Amgen Inc.
      • 14.3.11.1. Company Overview
      • 14.3.11.2. Financial Overview
      • 14.3.11.3. Product Portfolio
      • 14.3.11.4. Business Strategies
      • 14.3.11.5. Recent Developments
    • 14.3.12. GSK plc
      • 14.3.12.1. Company Overview
      • 14.3.12.2. Financial Overview
      • 14.3.12.3. Product Portfolio
      • 14.3.12.4. Business Strategies
      • 14.3.12.5. Recent Developments
    • 14.3.13. Sanofi
      • 14.3.13.1. Company Overview
      • 14.3.13.2. Financial Overview
      • 14.3.13.3. Product Portfolio
      • 14.3.13.4. Business Strategies
      • 14.3.13.5. Recent Developments
    • 14.3.14. Thermo Fisher Scientific Inc.
      • 14.3.14.1. Company Overview
      • 14.3.14.2. Financial Overview
      • 14.3.14.3. Product Portfolio
      • 14.3.14.4. Business Strategies
      • 14.3.14.5. Recent Developments
    • 14.3.15. AbbVie Inc.
      • 14.3.15.1. Company Overview
      • 14.3.15.2. Financial Overview
      • 14.3.15.3. Product Portfolio
      • 14.3.15.4. Business Strategies
      • 14.3.15.5. Recent Developments
    • 14.3.16. Bristol-Myers Squibb Company
      • 14.3.16.1. Company Overview
      • 14.3.16.2. Financial Overview
      • 14.3.16.3. Product Portfolio
      • 14.3.16.4. Business Strategies
      • 14.3.16.5. Recent Developments
    • 14.3.17. Teva Pharmaceutical Industries Ltd.
      • 14.3.17.1. Company Overview
      • 14.3.17.2. Financial Overview
      • 14.3.17.3. Product Portfolio
      • 14.3.17.4. Business Strategies
      • 14.3.17.5. Recent Developments
    • 14.3.18. Gilead Sciences, Inc.
      • 14.3.18.1. Company Overview
      • 14.3.18.2. Financial Overview
      • 14.3.18.3. Product Portfolio
      • 14.3.18.4. Business Strategies
      • 14.3.18.5. Recent Developments
    • 14.3.19. Biogen Inc.
      • 14.3.19.1. Company Overview
      • 14.3.19.2. Financial Overview
      • 14.3.19.3. Product Portfolio
      • 14.3.19.4. Business Strategies
      • 14.3.19.5. Recent Developments
    • 14.3.20. Moderna, Inc.
      • 14.3.20.1. Company Overview
      • 14.3.20.2. Financial Overview
      • 14.3.20.3. Product Portfolio
      • 14.3.20.4. Business Strategies
      • 14.3.20.5. Recent Developments

List of Tables

  • Table 01: Global Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 02: Global Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 03: Global Biotechnology Market Value (US$ Tn) Forecast, By Region, 2020 to 2035
  • Table 04: North America - Biotechnology Market Value (US$ Tn) Forecast, by Country, 2020 to 2035
  • Table 05: North America - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 06: North America - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 07: Europe - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 08: Europe - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 09: Europe - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 10: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 11: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 12: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 13: Latin America - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 14: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 15: Latin America - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 16: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 17: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 18: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035

List of Figures

  • Figure 01: Global Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 02: Global Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 03: Global Biotechnology Market Revenue (US$ Tn), by Polymerase Chain Reaction (PCR) Technology, 2020 to 2035
  • Figure 04: Global Biotechnology Market Revenue (US$ Tn), by Tissue Engineering and Regeneration, 2020 to 2035
  • Figure 05: Global Biotechnology Market Revenue (US$ Tn), by Nanobiotechnology, 2020 to 2035
  • Figure 06: Global Biotechnology Market Revenue (US$ Tn), by Chromatography, 2020 to 2035
  • Figure 07: Global Biotechnology Market Revenue (US$ Tn), by DNA Sequencing, 2020 to 2035
  • Figure 08: Global Biotechnology Market Revenue (US$ Tn), by Cell-based Assays, 2020 to 2035
  • Figure 09: Global Biotechnology Market Revenue (US$ Tn), by Fermentation, 2020 to 2035
  • Figure 10: Global Biotechnology Market Revenue (US$ Tn), by Bioinformatics, 2020 to 2035
  • Figure 11: Global Biotechnology Market Revenue (US$ Tn), by Others, 2020 to 2035
  • Figure 12: Global Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 13: Global Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 14: Global Biotechnology Market Revenue (US$ Tn), by Healthcare, 2020 to 2035
  • Figure 15: Global Biotechnology Market Revenue (US$ Tn), by Agriculture, 2020 to 2035
  • Figure 16: Global Biotechnology Market Revenue (US$ Tn), by Food & Beverages, 2020 to 2035
  • Figure 17: Global Biotechnology Market Revenue (US$ Tn), by Industrial Biotechnology, 2020 to 2035
  • Figure 18: Global Biotechnology Market Revenue (US$ Tn), by Environmental Biotechnology, 2020 to 2035
  • Figure 19: Global Biotechnology Market Revenue (US$ Tn), by Others, 2020 to 2035
  • Figure 20: Global Biotechnology Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Biotechnology Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 22: North America - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 23: North America - Biotechnology Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America - Biotechnology Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 25: North America - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 26: North America - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 27: North America - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 28: North America - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 29: Europe - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 30: Europe - Biotechnology Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 31: Europe - Biotechnology Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 32: Europe - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 33: Europe - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 34: Europe - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 35: Europe - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 36: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 37: Asia Pacific - Biotechnology Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 38: Asia Pacific - Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 39: Asia Pacific - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 40: Asia Pacific - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 41: Asia Pacific - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 42: Asia Pacific - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 43: Latin America - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 44: Latin America - Biotechnology Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 45: Latin America - Biotechnology Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 46: Latin America - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 47: Latin America - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 48: Latin America - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 49: Latin America - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 50: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 51: Middle East & Africa - Biotechnology Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 52: Middle East & Africa - Biotechnology Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 53: Middle East & Africa - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 54: Middle East & Africa - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 55: Middle East & Africa - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 56: Middle East & Africa - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035